B-cell receptor signaling in chronic lymphocytic leukemia leans on Lyn. (Q44022467)

29 November 2017

title

B-cell receptor signaling in chronic lymphocytic leukemia leans on Lyn. (English)

1 reference

chronic lymphocytic leukemia

29 November 2017

0 references

1 reference

Yair Herishanu

1

1 reference

29 November 2017

Aaron Polliack

series ordinal

2

1 reference

29 November 2017

publication date

8 January 2013

1 reference

29 November 2017

1 reference

29 November 2017

volume

54

1 reference

29 November 2017

issue

6

1 reference

29 November 2017

page(s)

1125-1126

1 reference

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

Expression levels of Lyn, Syk, PLCγ2 and ERK in patients with chronic lymphocytic leukemia, and higher levels of Lyn are associated with a shorter treatment-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.754097

10.3109/10428194.2012.754097

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference